tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Ritu Baral, 16 are a HOLD (8.56%), 170 are a BUY (90.91%), 1 are a SELL (0.53%).
Analyst Ritu Baral, currently employed at TD COWEN, carries an average stock price target met ratio of 53.08% that have a potential upside of 39.16% achieved within 448 days.
Ritu Baral’s has documented 357 price targets and ratings displayed on 39 stocks. The coverage is on Healthcare, Industrials, Basic Materials sectors.
Most recent stock forecast was given on ACAD, ACADIA Pharmaceuticals at 26-Feb-2026.
Analyst best performing recommendations are on SAGE (SAGE THERAPEUTIC).
The best stock recommendation documented was for SAGE (SAGE THERAPEUTIC) at 7/30/2024. The price target of $10 was fulfilled within 2 days with a profit of $0.8 (7.41%) receiving and performance score of 37.04.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 10-Mar-2021
$29
$6.8 (30.63%)
10 days ago
(25-Mar-2026)
10/12 (83.33%)
$6.99 (31.76%)
275
Buy Since 01-Mar-2024
$34
$11.8 (53.15%)
$31
1 months ago
(04-Mar-2026)
8/15 (53.33%)
$10.61 (45.36%)
113
Buy Since 23-Jun-2025
$30
$7.8 (35.14%)
$31
1 months 9 days ago
(26-Feb-2026)
0/6 (0%)
$5.36 (21.75%)
Buy Since 26-Nov-2019
$35
$12.8 (57.66%)
$34
1 months 9 days ago
(26-Feb-2026)
7/20 (35%)
$10.36 (42.05%)
274
Hold Since 20-Jun-2022
$24
$1.8 (8.11%)
$25
1 months 9 days ago
(26-Feb-2026)
17/19 (89.47%)
$-0.64 (-2.60%)
125
Which stock is Ritu Baral is most bullish on?
Which stock is Ritu Baral is most reserved on?
What Year was the first public recommendation made by Ritu Baral?
